Atlas Trials

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH

Clinical trial NCT04842032 · COMPLETED

Trial details

NCT number
NCT04842032
Sponsor
Kyowa Kirin Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
X-linked Hypophosphatemia (XLH)
Start date
2021-11-01
Primary completion
2023-12-18
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.